This brand name is authorized in Nigeria.
The drug BHUDEX contains one active pharmaceutical ingredient (API):
1
|
UNII
7S5I7G3JQL - DEXAMETHASONE
|
|
Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-6678 | Tablet | BUDEX Tablet TAB 0.5 mg 1 x 100's | Tablet 101 RNW-PP-310061 BHUDEX TABLET. DEXAMETHASONE BP 0.5MG EACH TABLET CONTAINS DEXAMETHASONE BP 0.5MG EXCIPIENTS starch, propylene glycol, magnesium stearate and lactose. B4-6678 Drugs Imported Products 1x100 Prescription Only Medicine (POM) 3/5/2023 NEXTPHARMA DRUG COMPANY LTD, 20 FARAYOLA STREET, ALAPERE KETU LAGOS STATE 8063803298 stevenext2019@gmail.com IMPULSE PHARMA PVT LTD, Plot No. J-201 J-20/1, M.I.D.C. Tarapur,Dist-Palghar, Biosar- 401 504, Maharashira, INDIA, India | 06/07/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| H02AB02 | Dexamethasone | H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-6678 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.